AMGN vs UTMD · P/E 24, rev $10.05B vs P/E 15, rev $17.3M
Amgen Inc (AMGN) versus Utah Medical Products Inc (UTMD) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Utah Medical Products Inc (UTMD) is a medical instruments & supplies company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported UTMD revenue for 2026-06-30 was $17.3M. Net income was $5.3M. Revenue was up 97.8% from 2026-03-31 to 2026-06-30. UTMD currently screens at market cap $189.8M and trailing P/E 15.4.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. UTMD currently screens at market cap $189.8M and trailing P/E 15.4.
Not investment advice. Open the AMGN and UTMD stock pages for the full models.
Not investment advice.